NHLBI Launching Catalyze Preclinical Services Program
The National Heart, Lung, and Blood Institute's (NHLBI) Catalyze Program initiatives support product development, including product definition small molecules, biologics, devices, diagnostics and enabling technologies and transformative platforms through five grant funding.
Catalyze preclinical services support preclinical development activities from end-stage proof-of-concept through preclinical development and US regulatory submissions. Preclinical services are tailored to the development needs of each product. Applicants can request specific services required to advance their technology to the clinic or regulatory submission. Interested applicants must submit an expression of interest (EOI) form online. EOI forms will be reviewed, and selected applicants are invited to submit a full application no later than Friday, March 17.
